Andreas Kerschbaumer
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
2022/11/10 by Josef S Smolen, Robert Landewé, Robert B M Landewé +63 · 43 citations
Medicine · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Biosimilars and Bioanalytical Methods #Hemophilia Treatment and Research
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
2020/01/22 by Josef S Smolen, Robert Landewé, Robert B M Landewé +62 · 31 citations
Medicine · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Biosimilars and Bioanalytical Methods #Systemic Lupus Erythematosus Research
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
2020/06/01 by Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer +37 · 29 citations
Medicine · Immunology and Microbiology · #Spondyloarthritis Studies and Treatments #Rheumatoid Arthritis Research and Therapies #Psoriasis: Treatment and Pathogenesis
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
2024/03/18 by Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira +46 · 32 citations
Medicine · Immunology and Microbiology · #Spondyloarthritis Studies and Treatments #Rheumatoid Arthritis Research and Therapies #Psoriasis: Treatment and Pathogenesis
- Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statement
2025/02/10 by Victoria Konzett, Josef S Smolen, Josef S. Smolen +15 · 7 citations
Medicine · #Rheumatoid Arthritis Research and Therapies #Spondyloarthritis Studies and Treatments #Cytokine Signaling Pathways and Interactions